Evidence map›Paper›PMID 41746032›Full record

ArticleTropical medicine and infectious disease2026

Enablers of Post-Validation Surveillance for Lymphatic Filariasis in the Pacific Islands: A Nominal Group Technique and Expert Elicitation.

Adam T Craig, Clement Couteaux, Ken Jetton, Roger Nehemia, Oliver Sokana, Tanebu Tong, Temea Bauro, Taulanga Baratio, Ofa Tukai, Joe Takai and 14 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Adam T CraigOperational Research and Decision Support for Infectious Diseases (ODeSI) Program, Centre for Clinical Research, The University of Queensland, Royal Brisbane Hospital, Herston, QLD 4029, Australia.ORCID 0000-0002-9287-8755
Clement CouteauxAgence de Santé of Wallis and Futuna, Sia Hospital, Hahake District, Wallis 98600, Wallis and Futuna.
Ken JettonRepublic of the Marshall Islands Ministry of Health and Human Services, P.O. Box 16, Majuro 96960, Marshall Islands.
Roger NehemiaTe Marae Ora Cook Islands Ministry of Health, Avarua P.O. Box 109, Rarotonga, Cook Islands.
Oliver SokanaSolomon Islands Ministry of Health and Medical Services, Honiara P.O. Box 349, Solomon Islands.
Tanebu TongKiribati Ministry of Health and Medical Services, Tarawa P.O. Box 268, Kiribati.
Temea BauroKiribati Ministry of Health and Medical Services, Tarawa P.O. Box 268, Kiribati.
Taulanga BaratioKiribati Ministry of Health and Medical Services, Tarawa P.O. Box 268, Kiribati.
Ofa TukaiTonga Ministry of Health, Nuku'alofa P.O. Box 59, Tonga.
Joe TakaiTonga Ministry of Health, Nuku'alofa P.O. Box 59, Tonga.
Satupaitea VialiOceania University of Medicine, Apia P.O. Box 232, Samoa.
Noel Gama SoaresTimor-Leste Ministry of Health, Palaco do Governo, Dili TL10001, Timor-Leste.
Maria Ome-KaiusPapua New Guinea Institute of Medical Research, Goroka P.O. Box 60, Papua New Guinea.
Mary YohoguPapua New Guinea Ministry of Health, Waigani 121, Port Moresby P.O. Box 807, Papua New Guinea.
Litiana VolavolaFiji Ministry of Health and Medical Services, Dinem House, 88 Amy Street, Toorak, Suva P.O. Box 2223, Fiji.
Patricia TatuiNiue Department of Health, Niue Foou Hospital, Alofi P.O. Box 40, Niue.
Fasihah TaleoWorld Health Organization Vanuatu Country Office, Port Vila P.O. Box 177, Vanuatu.
Salanieta SaketaPublic Health Division, Pacific Community, Suva P.O. Box 2223, Fiji.
Andie TuckerGlobal Alliance to Eliminate Lymphatic Filariasis, Decatur, GA 30030, USA.
Charles MackenzieGlobal Alliance to Eliminate Lymphatic Filariasis, Decatur, GA 30030, USA.ORCID 0000-0003-4628-8188
Katherine GassTask Force for Global Health, Decatur, GA 30030, USA.ORCID 0000-0002-2084-8039
Holly JianOperational Research and Decision Support for Infectious Diseases (ODeSI) Program, Centre for Clinical Research, The University of Queensland, Royal Brisbane Hospital, Herston, QLD 4029, Australia.ORCID 0009-0006-3559-3055
Colleen L LauOperational Research and Decision Support for Infectious Diseases (ODeSI) Program, Centre for Clinical Research, The University of Queensland, Royal Brisbane Hospital, Herston, QLD 4029, Australia.ORCID 0000-0001-8288-4169
Harriet L S LawfordOperational Research and Decision Support for Infectious Diseases (ODeSI) Program, Centre for Clinical Research, The University of Queensland, Royal Brisbane Hospital, Herston, QLD 4029, Australia.ORCID 0000-0002-9699-8201

Funding

HERA scheme NA
6 · The paper itself

Abstract

Lymphatic filariasis (LF) is a mosquito-borne neglected tropical disease that causes substantial morbidity and social exclusion. Global efforts under the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis have markedly reduced prevalence, and several Pacific Island Countries and Territories (PICTs) have achieved elimination of the disease as a public health problem. However, post-validation surveillance (PVS), essential for detecting resurgence and enabling early response, has rarely been implemented, and barriers to its delivery remain poorly understood. We used two complementary qualitative approaches to identify systemic barriers and enablers to LF PVS in PICTs. First, we conducted a Nominal Group Technique followed by a structured expert elicitation involving program managers and technical staff. Data were analysed thematically and triangulated across sources. Participants identified 70 challenges which were consolidated into ten thematic domains. Pertinent barriers relate to limited leadership understanding of LF and surveillance options, inconsistent technical and financial support, and a lack of context-appropriate operational guidance. Additional challenges included limited field-ready diagnostics, procurement delays, the absence of formal mandates, and low community engagement. Enablers included embedding PVS within existing health services, leveraging trusted community networks, strengthening regional frameworks, and co-developing practical tools with countries. Sustaining LF elimination in the Pacific will require political commitment, regional collaboration, and integrated, programmatic approaches informed by recent PVS experience.

Indexed as

eliminationhealth systemslymphatic filariasisneglected tropical diseasesnominal group techniquePacific Islandspost-validation surveillance

Identifiers

PMID41746032
PMCPMC12944890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.